Miracle on Ice Congressional Gold Medal Act This act provides for the award of Congressional Gold Medals to the members of the 1980 U.S. Olympic men's ice hockey team in recognition of the team's achievement at the 1980 Winter Olympic Games.
Maddy summaryHR 6582, the Flight Risk Reduction Act, changes federal pretrial detention rules for non-citizens facing criminal charges. It creates a legal presumption that non-citizens (not U.S. citizens or lawful permanent residents) cannot be released before trial unless they prove they won’t skip court or harm others, using "clear and convincing evidence." The bill specifically states that having family or jobs in the U.S. cannot be used to challenge this presumption. This directly affects non-citizens charged in federal court who might otherwise seek pretrial release.
Maddy summaryThe Freedom to Heal Act of 2025 creates a new federal registration process for physicians to directly administer Schedule I investigational drugs under the "Right to Try" framework. It requires physicians to apply to the Attorney General with evidence of state compliance, manufacturer agreements, and training, and limits the amount of drugs they may possess based on approved applications. The bill mandates the Attorney General to issue interim rules within 240 days and final rules within two years covering drug delivery, storage, recordkeeping, and registration management. This affects physicians treating eligible patients with Schedule I drugs under federal Right to Try provisions, not the patients themselves.
Maddy summaryHR 4305, the DUMP Red Tape Act, creates a Small Business Administration hotline for small businesses to report regulatory burdens they face when complying with federal agency rules. Small businesses (as defined by the Small Business Act) can submit complaints via email, website, or phone through this hotline, which must be established within 180 days of the bill's enactment. The Chief Counsel for Advocacy must then submit annual reports to Congress detailing the most frequently reported rules, affected industries, geographic data, and recommendations for agencies to address these burdens. This bill establishes a reporting mechanism but does not directly change existing regulations.
Maddy summaryThe CARE Act of 2025 limits refugee resettlement by prohibiting the U.S. government from resettling refugees in any state or locality that has formally disapproved resettlement through its governor, state legislature, or local government officials. It amends the Immigration and Nationality Act to block resettlement funding in jurisdictions with such formal disapproval actions during any fiscal year. The bill directly affects refugees seeking resettlement and state/local governments that take formal opposition to refugee arrivals. Key provisions require explicit disapproval by elected officials at the state or local level to restrict resettlement, without exceptions for federal oversight. This policy change creates a new administrative barrier to refugee resettlement based on local political decisions.
Maddy summaryThis bill would amend the Anti-Terrorism Act of 1987 to designate the Muslim Brotherhood as a terrorist organization and prohibit its operations within the United States. It would require the President to designate the Muslim Brotherhood as a foreign terrorist organization under immigration law and impose new visa restrictions, including immediate revocation of current visas, for individuals identified as members. The bill mandates annual reports from the Secretary of State identifying Muslim Brotherhood branches worldwide and determining which should be designated as terrorist organizations under existing laws. These provisions would directly affect Muslim Brotherhood members, branches, and affiliated organizations seeking entry to or operating within the United States.
Maddy summaryThis bill amends federal labeling rules for beef products sold in the U.S. It requires clear country-of-origin labeling for beef (including ground beef), expanding existing rules that previously covered lamb and venison. The key change increases penalties for non-compliance: $5,000 per pound of beef sold without required labeling, compared to $1,000 per violation for other meats. These rules directly affect meat producers, processors, and retailers selling beef products. The bill also ensures U.S. labeling authority cannot be overridden by international trade rulings.
Maddy summaryHR 5716, the FARM SAFE Act, ensures that USDA employees administering key agricultural disaster programs cannot be furloughed or laid off during government shutdowns. It directly affects USDA staff working on programs like crop insurance, livestock aid, and other federal disaster assistance authorized under the Agricultural Credit Act of 1978 and the Agricultural Act of 2014. The bill requires these employees to be treated as "excepted" under federal law during funding gaps, guaranteeing program continuity without requiring new appropriations. This provides immediate stability for farmers relying on disaster relief during federal budget disruptions.
Maddy summaryHR 4549, the Office of Rural Affairs Enhancement Act, amends the Small Business Administration's structure to better serve rural small businesses. It requires the Office's Assistant Administrator to have specific rural business expertise and mandates new outreach activities, including regional webinars and events for rural small business owners. The bill also adds annual reporting requirements for the SBA, detailing the Office's budget, staff, outreach events, and analysis of lending programs targeting rural businesses. These changes directly affect rural small business concerns (defined as those in rural areas per SBA rules) and the SBA's operational approach to their support. The legislation focuses on strengthening the Office's capacity to connect rural businesses with federal resources.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
